ZA914839B - Bioceramic system for delivery of bioactive compounds - Google Patents

Bioceramic system for delivery of bioactive compounds

Info

Publication number
ZA914839B
ZA914839B ZA914839A ZA914839A ZA914839B ZA 914839 B ZA914839 B ZA 914839B ZA 914839 A ZA914839 A ZA 914839A ZA 914839 A ZA914839 A ZA 914839A ZA 914839 B ZA914839 B ZA 914839B
Authority
ZA
South Africa
Prior art keywords
bioactive
delivery
bioceramic system
bioactive compounds
compound
Prior art date
Application number
ZA914839A
Other languages
English (en)
Inventor
Antti Uuno Uolevi Yli-Urpo
Uuno Uolevi Yli-Urpo Antti
Harry Goesta Jalonen
Goesta Jalonen Harry
Kauko Oiva Antero Kurkela
Oiva Antero Kurkela Kauko
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ZA914839B publication Critical patent/ZA914839B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/08—Stiffening bandages containing inorganic materials, e.g. plaster of Paris
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0007—Compositions for glass with special properties for biologically-compatible glass

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Geochemistry & Mineralogy (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Glass Compositions (AREA)
ZA914839A 1990-06-25 1991-06-24 Bioceramic system for delivery of bioactive compounds ZA914839B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9014052A GB2245559A (en) 1990-06-25 1990-06-25 Bioceramic system for delivery of a bioactive compound.

Publications (1)

Publication Number Publication Date
ZA914839B true ZA914839B (en) 1992-04-29

Family

ID=10678130

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA914839A ZA914839B (en) 1990-06-25 1991-06-24 Bioceramic system for delivery of bioactive compounds

Country Status (17)

Country Link
US (1) US5762950A (de)
EP (1) EP0536179B1 (de)
JP (1) JPH05507867A (de)
KR (1) KR930700166A (de)
AT (1) ATE161737T1 (de)
AU (1) AU652945B2 (de)
DE (1) DE69128621T2 (de)
FI (1) FI925845A0 (de)
GB (1) GB2245559A (de)
HU (1) HUT64214A (de)
IE (1) IE912191A1 (de)
NZ (1) NZ238675A (de)
PL (2) PL166849B1 (de)
PT (1) PT98080B (de)
SK (1) SK377792A3 (de)
WO (1) WO1992000109A1 (de)
ZA (1) ZA914839B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
US5851993A (en) * 1994-06-13 1998-12-22 Biotie Therapies Ltd. Suppression of tumor cell growth by syndecan-1 ectodomain
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
AU771272B2 (en) * 1995-06-13 2004-03-18 Zahra Mansouri Methods of delivering materials into the skin and compositions used therein
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US6579516B1 (en) * 1995-06-13 2003-06-17 Zahra Mansouri Methods of delivering materials into the skin, and compositions used therein
AU3069997A (en) * 1996-05-01 1997-11-19 Us Biomaterials Corporation Bioactive ceramics and method of preparing bioactive ceramics
CA2268156C (en) * 1996-10-16 2007-05-29 Etex Corporation Bioceramic compositions
FI103715B1 (fi) * 1997-04-21 1999-08-31 Heimo Ylaenen Uusi komposiitti ja sen käyttö
TW496741B (en) * 1998-03-12 2002-08-01 Dept Of Health R O C Radioactive particles and method for producing the same
CN1360491A (zh) * 1999-07-09 2002-07-24 肖特玻璃制造厂 用于易腐制剂,特别是化妆和药物制剂的防腐剂
GB9919283D0 (en) * 1999-08-14 1999-10-20 Algar Brian A glass composition
US7323160B2 (en) * 1999-08-14 2008-01-29 Teldent Ltd. Method of treating a patient's teeth using fluoride releasing glass composition
WO2001072145A1 (en) * 2000-03-24 2001-10-04 Ustherapeutics, Llc Nutritional supplements formulated from bioactive materials
BR0109991A (pt) * 2000-04-11 2003-05-27 Sankyo Co Composição farmacêutica
JP2006500115A (ja) 2000-11-16 2006-01-05 マイクロスフエリツクス・エル・エル・シー 密封小線源治療用の可撓性および／または弾性シードまたはストランド
US6746661B2 (en) * 2000-11-16 2004-06-08 Microspherix Llc Brachytherapy seed
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
US8168208B1 (en) * 2002-06-03 2012-05-01 Ahmed El-Ghannam Silica-calcium phosphate bioactive composite for improved synthetic graft resorbability and tissue regeneration
TWI283657B (en) * 2002-07-15 2007-07-11 Pentax Corp CaO-SiO2-based bioactive glass and sintered calcium phosphate glass using same
DE10307646B3 (de) 2003-02-21 2004-10-21 Ivoclar Vivadent Ag Bioaktive Rhenanit-Glaskeramik, Verfahren zu ihrer Herstellung und ihre Verwendung
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
CN1819821B (zh) * 2003-08-08 2010-10-13 拜奥维尔实验室国际股份有限公司 盐酸安非他酮的改良释放片剂
AU2005306869B2 (en) * 2004-11-16 2011-11-10 3M Innovative Properties Company Dental fillers including a phosphorus­containing surface treatment
AU2005306857A1 (en) * 2004-11-16 2006-05-26 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
CN101098673B (zh) * 2004-11-16 2012-02-29 3M创新有限公司 包括磷酸盐的牙科填料和组合物
CA2587278A1 (en) * 2004-11-16 2006-05-26 3M Innovative Properties Company Dental fillers, methods, compositions including a caseinate
EP1909859B1 (de) * 2005-07-21 2017-09-06 aap Biomaterials GmbH Verfahren zur herstellung von hydroxylapatit-teilchen, insbesondere von subnanodispersen hydroxylapatit-teilchen in einer matrix
US8187159B2 (en) 2005-07-22 2012-05-29 Biocompatibles, UK Therapeutic member including a rail used in brachytherapy and other radiation therapy
US7736293B2 (en) * 2005-07-22 2010-06-15 Biocompatibles Uk Limited Implants for use in brachytherapy and other radiation therapy that resist migration and rotation
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
US20080241256A1 (en) * 2007-03-30 2008-10-02 Liisa Kuhn Targeted active agent delivery system based on calcium phosphate nanoparticles
EP2229130A2 (de) * 2007-12-13 2010-09-22 3M Innovative Properties Company Remineralisierende zusammensetzungen und verfahren
WO2010068359A1 (en) * 2008-12-11 2010-06-17 3M Innovative Properties Company Surface-treated calcium phosphate particles suitable for oral care and dental compositions
CN103006700B (zh) * 2011-09-20 2016-08-17 常州倍尔生生物科技有限公司 pH缓冲生物活性玻璃及其制备方法和用途
US11896612B2 (en) * 2019-03-29 2024-02-13 Board Of Trustees Of Michigan State University Resurrection of antibiotics that MRSA resists by silver-doped bioactive glass-ceramic particles
WO2023187225A1 (en) * 2022-04-01 2023-10-05 Amplicon Ab Alkaline intraoral products

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135935A (en) * 1973-09-17 1979-01-23 Ernst Leitz Wetzlar Gmbh Sintered composite material, a process of making same, and a method of using same
DE2501683C3 (de) * 1975-01-17 1979-11-29 Ernst Leitz Wetzlar Gmbh, 6300 Wetzlar Polymeres Verbundmaterial für prothetische Zwecke und Verfahren zu seiner Herstellung
CH595293A5 (de) * 1975-02-20 1978-02-15 Battelle Memorial Institute
JPS5839533B2 (ja) * 1975-12-30 1983-08-30 住友化学工業株式会社 インプラントノセイゾウホウホウ
US4334029A (en) * 1980-01-09 1982-06-08 Mizusawa Kazahu Kogyo Kabushiki Kaisha Unfired refractory composition
JPS59101145A (ja) * 1982-11-30 1984-06-11 日本特殊陶業株式会社 薬液含浸多孔質セラミツクス
GB8331661D0 (en) * 1983-11-26 1984-01-04 Standard Telephones Cables Ltd Water soluble glass composition
US4655777A (en) * 1983-12-19 1987-04-07 Southern Research Institute Method of producing biodegradable prosthesis and products therefrom
JPS60186455A (ja) * 1984-03-06 1985-09-21 株式会社ニコン アパタイトコンポジツトセラミクス
CH665357A5 (de) * 1985-07-05 1988-05-13 Werther Lusuardi Knochenzement.
JPS6272540A (ja) * 1985-09-26 1987-04-03 Nippon Electric Glass Co Ltd 無アルカリ生体用結晶化ガラスとその製造方法
US4780450A (en) * 1985-12-20 1988-10-25 The University Of Maryland At Baltimore Physically stable composition and method of use thereof for osseous repair
EP0261593B1 (de) * 1986-09-24 1992-08-26 Lion Corporation Verfahren zur Herstellung eines Gelvorläufers eines bioaktiven Glases oder einer bioaktiven Glaskeramik
JPS6456056A (en) * 1987-08-26 1989-03-02 Dental Chem Co Ltd Hydroxyapatite bone filling material
JPH01172240A (ja) * 1987-12-26 1989-07-07 Central Glass Co Ltd 斑状模様入ガラス質焼成体およびその製法
JPH01265969A (ja) * 1988-04-19 1989-10-24 Asahi Glass Co Ltd 生体用材料及びその製造方法
JPH01275765A (ja) * 1988-04-28 1989-11-06 Seiko Epson Corp インプラント材の製造方法
JPH0629126B2 (ja) * 1989-03-29 1994-04-20 京都大学長 生体活性水酸アパタイト膜のコーティング法
US5356436A (en) * 1989-06-06 1994-10-18 Tdk Corporation Materials for living hard tissue replacements
US5232878A (en) * 1989-06-30 1993-08-03 Hoya Corporation Process for producing inorganic biomaterial
FR2651439B1 (fr) * 1989-09-06 1994-09-23 Fbfc International Sa Nv Materiau bioreactif pour prothese ou implants composites.
DD291982A5 (de) * 1990-02-12 1991-07-18 ���������`��������`����@����k�� Apatitglaskeramik, vorzugsweise fuer dentale glasionomerzemente
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
US5074916A (en) * 1990-05-18 1991-12-24 Geltech, Inc. Alkali-free bioactive sol-gel compositions
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
US5262166A (en) * 1991-04-17 1993-11-16 Lty Medical Inc Resorbable bioactive phosphate containing cements

Also Published As

Publication number Publication date
KR930700166A (ko) 1993-03-13
SK377792A3 (en) 1995-01-12
PT98080A (pt) 1992-04-30
AU652945B2 (en) 1994-09-15
EP0536179A1 (de) 1993-04-14
IE912191A1 (en) 1992-01-01
ATE161737T1 (de) 1998-01-15
JPH05507867A (ja) 1993-11-11
PL166849B1 (pl) 1995-06-30
PL166919B1 (pl) 1995-07-31
GB2245559A (en) 1992-01-08
AU8082391A (en) 1992-01-23
FI925845A7 (fi) 1992-12-23
EP0536179B1 (de) 1998-01-07
GB9014052D0 (en) 1990-08-15
NZ238675A (en) 1993-04-28
HUT64214A (en) 1993-12-28
FI925845L (fi) 1992-12-23
FI925845A0 (fi) 1992-12-23
DE69128621D1 (de) 1998-02-12
WO1992000109A1 (en) 1992-01-09
DE69128621T2 (de) 1998-05-07
PT98080B (pt) 1998-11-30
US5762950A (en) 1998-06-09

Similar Documents

Publication Publication Date Title
GB9014052D0 (en) Bioceramic system for delivery of a bioactive compound
FR05C0045I2 (de)
BG102259A (en) Compostions with controlled paroxetine release
YU28199A (sh) Novi oblik jedinjenja
EP0386757A3 (en) Biodegradable poly (phosphate esters)
ZA935569B (en) Controlled release implants
ZA977524B (en) Process for the preparation of bone cements comprising active compound.
IL109032A0 (en) Compositions for controlled release of biologically active tgf-beta
TR199900083T2 (xx) Klaritromisinin kristal bi�imi I.
AU1575488A (en) Bioerodable implant composition
GR3015767T3 (en) Novel controlled release formulations of tetracycline compounds.
MY136231A (en) Slow release compositions
GR3026322T3 (en) Process for the preparation of pure polylactide.
ZA933768B (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism.
GB2241945B (en) Composition for the treatment of aqueous systems
AU2361792A (en) Preparing grafts for implantation
CA2138367A1 (en) Use of Phosphonates for the Treatment of Osteoporosis
CA2296110A1 (en) Silver-palladium alloys for dental prostheses
AU632095B2 (en) Orthopaedic implant
HUP0004033A3 (en) Controlled release fertilizer compositions and processes for the preparation thereof
EP0326155A3 (en) Polyaluminum dialkyl phosphate, oil gelling agent comprising the same, and composition for external application comprising the same
NO925003L (no) Biokeramisk system for levering av bioaktive komponenter
SG153894G (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
YU28999A (sh) Postupak za kristalisanje derivata tetrahidropiridina i dobijeni kristalni oblici
RU92016566A (ru) Биокерамическая система для ввода биологически активных соединений, способ ее получения, фармацевтическое средство, способ применения биокерамической системы